The relevance of cell kinetics for optimal scheduling of 1-?-d-Arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML)
- 1 January 1978
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 1 (4) , 219-223
- https://doi.org/10.1007/bf00257153
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- TIMED SEQUENTIAL THERAPY OF HUMAN LEUKEMIA BASED UPON RESPONSE OF LEUKEMIC-CELLS TO HUMORAL GROWTH-FACTORS1977
- Cell kinetics and cancer therapy: history, present status, and challenges.1976
- EFFECT OF METHOTREXATE ON THE CELL CYCLE OF L1210 LEUKEMIACell Proliferation, 1976
- In vitro colony formation of transplantable rat leukemias in comparison with human acute myeloid leukemia.1976
- Manipulation of the Mitotic Cycle in the Treatment of Acute Myelogenous LeukaemiaBritish Journal of Haematology, 1976
- The cell cycle and its significance for cancer treatmentCancer Treatment Reviews, 1975
- Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapyArchives of internal medicine (1960), 1975
- Enhancement of the antiproliferative action of 1- -D-arabinofuranosylcytosine by methotrexate in murine leukemic cells (L5178Y).1973
- Effect of 1-beta-D-arabinofuranosylcytosine on cell cycle passage time.1970
- Kinetics of normal and leukemic leukocyte populations and relevance to chemotherapy.1970